CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 120 filers reported holding CARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $47,096,000 | +17.1% | 2,169,351 | -18.4% | 0.20% | +5.7% |
Q4 2020 | $40,212,000 | +48.8% | 2,657,796 | +25.1% | 0.19% | +38.1% |
Q3 2020 | $27,033,000 | -17.3% | 2,124,421 | +11.2% | 0.14% | -26.5% |
Q2 2020 | $32,675,000 | +71.5% | 1,910,821 | +32.5% | 0.19% | +53.7% |
Q1 2020 | $19,054,000 | -18.0% | 1,442,421 | 0.0% | 0.12% | +5.1% |
Q4 2019 | $23,237,000 | -31.9% | 1,442,421 | -22.7% | 0.12% | -37.8% |
Q3 2019 | $34,113,000 | -18.1% | 1,866,188 | -3.7% | 0.19% | -18.6% |
Q2 2019 | $41,671,000 | +116.5% | 1,938,188 | +97.5% | 0.23% | +108.1% |
Q1 2019 | $19,251,000 | +77.0% | 981,220 | +17.3% | 0.11% | +63.2% |
Q4 2018 | $10,876,000 | -18.5% | 836,642 | +50.2% | 0.07% | -4.2% |
Q3 2018 | $13,340,000 | +25.1% | 557,000 | 0.0% | 0.07% | +16.4% |
Q2 2018 | $10,666,000 | +373.2% | 557,000 | +205.9% | 0.06% | +369.2% |
Q1 2018 | $2,254,000 | +80.6% | 182,100 | +78.5% | 0.01% | +85.7% |
Q4 2017 | $1,248,000 | – | 102,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |